Nicholas Brousseau
Chercheur associé
Axe Maladies infectieuses et immunitaires
Publications
View all-
article Killikelly A, Siu W, Brousseau N
Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance to protect infants and children from respiratory syncytial virus disease
Can Commun Dis Rep 52 (6), 2026.
-
article Zafack J, Abrams EM, Brousseau N
Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on respiratory syncytial virus (RSV) vaccines for older adults and for adults at hig…
Can Commun Dis Rep 52 (6), 2026.
-
article Gebretekle GB, Lan M, Xi M, Ximenes R, Buchan SA, Abrams EM, Andrew MK, Brousseau N, Killikelly A, Money D, Papenburg J, Rafferty E, Robinson JL, Siu W, Tunis M, Tuite AR
Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis
PLoS One 21 (6), 2026.
Projects
- Enquête cas témoins sur l'efficacité des vaccins contre les infections invasives à pneumocoques, from 2022-04-01 to 2027-03-31
- Évaluation de l'impact des modifications apportées à la vaccination contre la coqueluche au Québec - Phase 3, from 2024-08-12 to 2027-07-31
- RV01 QC44, REVivED Network Site Support, from 2025-02-01 to 2028-03-31
- Immuno VHB 2/3 doses nourissons, from 2017-12-20 to 2026-03-31
- Évaluation de l'impact des modifications apportées à la vaccination contre la coqueluche au Québec, from 2020-07-27 to 2025-06-30
- Does a reduced-dose RotaTeq (RV5) vaccine schedule translate into a higher incidence of rotavirus infections compared to approved RV5 schedules?, from 2023-06-01 to 2026-03-31